Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Express Scripts
Colorcon
Medtronic
Merck

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Adapt Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ADAPT, and what generic and branded alternatives to ADAPT drugs are available?

ADAPT has six approved drugs.



Summary for Adapt
US Patents:0
Tradenames:5
Ingredients:5
NDAs:6
Patent Litigation for Adapt: See patent lawsuits for Adapt

Drugs and US Patents for Adapt

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Adaptis MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 209012-001 Apr 24, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free
Adaptis BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 211020-002 Jan 28, 2019 AB3 RX No No ⤷  Try it Free ⤷  Try it Free
Adapt NARCAN naloxone hydrochloride INJECTABLE;INJECTION 016636-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try it Free ⤷  Try it Free
Adaptis MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 209011-002 Apr 18, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free
Adaptis FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 211626-001 Jul 18, 2019 AB RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ADAPT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Nasal Spray 4 mg/spray ➤ Subscribe 2016-07-15
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.